SOURCE: MyDx, Inc.

MyDx, Inc. Logo

May 29, 2015 07:30 ET

MyDx Announces Up-Listing to OTCQB Marketplace

SAN DIEGO, CA--(Marketwired - May 29, 2015) - MyDx, Inc. (OTCQB: MYDX), creator of MyDx™ (My Diagnostic), the first handheld chemical analyzer for consumers, has successfully up-listed to the OTCQB Marketplace. MyDx offers a quick, easy and affordable way for consumers to test the safety and composition of what they eat, drink and inhale.

"Following our recent completion of a reverse merger, we quickly followed through with our intention to up-list to the OTCQB," said Daniel Yazbeck, CEO of MyDx, Inc. "MyDx is committed to the high level of financial and corporate disclosure that is required for the listing, which demonstrates our continued commitment to our shareholders. We believe that trading on the OTCQB will raise the visibility of the Company, enhance trading liquidity, and broaden our shareholder base as we move forward with bringing our first analyzer to market, which includes the CannaDx™ sensor."

The Company plans to build on its successful progression and will continue working towards meeting the listing requirements for trading on a stock exchange such as the NASDAQ in the future.

About MyDx, Inc.
MyDx, Inc. (OTCQB: MYDX) is a science and technology company based in San Diego, California whose mission is to empower people to live a healthier life by revealing the chemicals in what they eat, drink and inhale. The Company has developed MyDx™, a portable analyzer that provides real-time chemical analysis and fits in the palm of your hands. MyDx leverages over a decade of established electronic nose technology to measure chemicals of interest and has four sensors being developed in its lab that are compatible with the MyDx™ App. For more information, please visit www.cdxlife.com.

Safe Harbor
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov.

Contact Information

  • Company Contact:
    MyDx, Inc.
    Skip Sanzeri
    President
    Tel 1-800-814-4550
    skip@cdxlife.com

    Investor Relations Contact:
    MZ North America
    Greg Falesnik
    Senior Vice President
    Tel 1-949-385-6449
    Greg.Falesnik@mzgroup.us